InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,895.92
(
0.43%
)
US TECH 100
20,043.20
(
0.91%
)
Dow Jones
43,436.87
(
-0.02%
)
Brent Oil
72.81
(
2.98%
)
Bitcoin
92,479.07
(
2.91%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Bxofscidad

Send PM Follow Ignore
Followers 0
Posts 232
Boards Moderated 0
Alias Born 06/13/2010

Bxofscidad

Re: None

Friday, 09/21/2012 10:05:53 AM

Friday, September 21, 2012 10:05:53 AM

Post# of 80490
Do you think he is referring to "113"?


On the Esmo website, Scientific Chairman Josep Tabernero, in highlighting a few of the more important abstracts, refers to
"study results offering for the first time directions on how to treat patients with a certain EGFR mutation"


I sure hope he is referring to 113, but if any on the board have any idea about what he is referring to, please share it with us.


Go to the ESMO site, click on "Press" and read what abstracts he is highlighting.


Barry





Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up